Kevan Shokat

Kevan Shokat is a professor at UCSF and co-founder of Rezo Therapeutics, where his work connects chemical biology and drug discovery. His research has helped show how KRAS, long considered undruggable, can be targeted with drugs; he is also a professor at UC Berkeley and an investigator with the Howard Hughes Medical Institute.

Career